Stockreport

ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing

ProMIS Neurosciences Inc. - Common Shares  (PMN) 
PDF Extends cash runway into 2028 Proceeds expected to enable completion of ProMIS’ landmark  Phase 1b AD study and support execution of key clinical milestones Bli [Read more]